Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Gibson Christopher
May 3 18:27 ET
Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Borgeson Blake
May 2 17:45 ET
Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
May 2 10:48 ET
Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
May 1 12:54 ET
Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Apr 30 16:27 ET
Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Marriott Tina
Apr 29 18:45 ET
Recursion Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Khan Najat
Apr 25 17:11 ET
Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Apr 25 16:09 ET
Recursion Pharmaceuticals | ARS: Annual Report to Security Holders
Apr 23 17:31 ET
Recursion Pharmaceuticals | DEFA14A: Others
Apr 23 17:21 ET
Recursion Pharmaceuticals | DEF 14A: Definitive information statements
Apr 23 17:21 ET
Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Borgeson Blake
Apr 18 17:17 ET
Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Secora Michael
Apr 18 17:17 ET
Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Apr 17 16:21 ET
Recursion Pharmaceuticals | 144/A: Others
Apr 16 17:01 ET
Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Apr 16 16:21 ET
Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Apr 16 16:11 ET
Recursion Pharmaceuticals | 8-K: Current report
Apr 16 08:05 ET
Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Gibson Christopher
Apr 5 17:49 ET
Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Apr 4 11:15 ET
No Data
No Data